Double Medical Technology Inc. (SHE:002901)
China · Delayed Price · Currency is CNY 51.83
+1.79 (3.58%)
Nov 3, 2025, 2:45 PM CST
Double Medical Technology Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Jan '22 Jan 1, 2022 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
Operating Revenue | 2,466 | 2,119 | 1,525 | 1,428 | 1,989 | 1,583 | Upgrade |
Other Revenue | 16.7 | 16.7 | 8.39 | 5.94 | 5.02 | 3.39 | Upgrade |
| 2,483 | 2,136 | 1,533 | 1,434 | 1,994 | 1,587 | Upgrade | |
Revenue Growth (YoY) | 28.17% | 39.30% | 6.91% | -28.09% | 25.68% | 26.21% | Upgrade |
Cost of Revenue | 767.86 | 710.15 | 541.52 | 344.6 | 319.12 | 230.65 | Upgrade |
Gross Profit | 1,715 | 1,425 | 991.6 | 1,089 | 1,675 | 1,356 | Upgrade |
Selling, General & Admin | 828.36 | 769.03 | 690.5 | 788.18 | 746.94 | 565.3 | Upgrade |
Research & Development | 342.48 | 306.87 | 285.28 | 256.72 | 167.07 | 128.02 | Upgrade |
Other Operating Expenses | 3.21 | 9.1 | -2.51 | 15.77 | 27.52 | 21.51 | Upgrade |
Operating Expenses | 1,181 | 1,091 | 972.13 | 1,059 | 957.77 | 723.13 | Upgrade |
Operating Income | 533.37 | 334.38 | 19.47 | 30.9 | 717.45 | 633.08 | Upgrade |
Interest Expense | -5.87 | -6.49 | -7.16 | -3.1 | -0.55 | - | Upgrade |
Interest & Investment Income | 36.96 | 44.78 | 39.65 | 37.23 | 34.63 | 28.53 | Upgrade |
Currency Exchange Gain (Loss) | -11.35 | -11.35 | 0.77 | 7.62 | -5.87 | -10.05 | Upgrade |
Other Non Operating Income (Expenses) | 15.64 | -0.16 | -0.54 | -0.32 | -0.2 | -0.14 | Upgrade |
EBT Excluding Unusual Items | 568.75 | 361.16 | 52.19 | 72.33 | 745.45 | 651.42 | Upgrade |
Impairment of Goodwill | -0.5 | -0.5 | -0.86 | -1.37 | -0.91 | - | Upgrade |
Gain (Loss) on Sale of Investments | 39.78 | 3.11 | 5.6 | 1.77 | 1.22 | 2.52 | Upgrade |
Gain (Loss) on Sale of Assets | 0.63 | 0.27 | 0.3 | -1.73 | -0 | -0.12 | Upgrade |
Asset Writedown | -18.38 | -0.43 | -0.02 | -0.54 | -0.03 | -0.06 | Upgrade |
Legal Settlements | - | - | - | - | -19.1 | -2.4 | Upgrade |
Other Unusual Items | 64.81 | 64.81 | 42.51 | 77 | 75.88 | 58.28 | Upgrade |
Pretax Income | 655.09 | 428.41 | 99.72 | 147.46 | 802.51 | 709.63 | Upgrade |
Income Tax Expense | 84.13 | 43.12 | 13.4 | 37.89 | 111.01 | 94.88 | Upgrade |
Earnings From Continuing Operations | 570.97 | 385.29 | 86.32 | 109.57 | 691.5 | 614.75 | Upgrade |
Minority Interest in Earnings | -29.39 | -28.49 | -27.36 | -17.01 | -18.19 | -9.07 | Upgrade |
Net Income | 541.57 | 356.8 | 58.96 | 92.56 | 673.31 | 605.68 | Upgrade |
Net Income to Common | 541.57 | 356.8 | 58.96 | 92.56 | 673.31 | 605.68 | Upgrade |
Net Income Growth | 169.28% | 505.16% | -36.30% | -86.25% | 11.16% | 30.12% | Upgrade |
Shares Outstanding (Basic) | 409 | 415 | 421 | 421 | 401 | 401 | Upgrade |
Shares Outstanding (Diluted) | 409 | 415 | 421 | 421 | 403 | 401 | Upgrade |
Shares Change (YoY) | -2.80% | -1.49% | 0.10% | 4.35% | 0.52% | -0.04% | Upgrade |
EPS (Basic) | 1.32 | 0.86 | 0.14 | 0.22 | 1.68 | 1.51 | Upgrade |
EPS (Diluted) | 1.32 | 0.86 | 0.14 | 0.22 | 1.67 | 1.51 | Upgrade |
EPS Growth | 177.03% | 514.29% | -36.36% | -86.83% | 10.60% | 30.17% | Upgrade |
Free Cash Flow | 558.36 | 171.84 | -231.82 | -156.63 | 438.15 | 418.64 | Upgrade |
Free Cash Flow Per Share | 1.36 | 0.41 | -0.55 | -0.37 | 1.09 | 1.04 | Upgrade |
Dividend Per Share | 0.500 | 0.500 | 0.250 | - | 0.500 | 0.800 | Upgrade |
Dividend Growth | 100.00% | 100.00% | - | - | -37.50% | 33.33% | Upgrade |
Gross Margin | 69.07% | 66.75% | 64.68% | 75.97% | 84.00% | 85.47% | Upgrade |
Operating Margin | 21.49% | 15.66% | 1.27% | 2.15% | 35.97% | 39.90% | Upgrade |
Profit Margin | 21.82% | 16.71% | 3.85% | 6.45% | 33.76% | 38.17% | Upgrade |
Free Cash Flow Margin | 22.49% | 8.05% | -15.12% | -10.92% | 21.97% | 26.38% | Upgrade |
EBITDA | 653.74 | 446.79 | 121.28 | 117.12 | 782.07 | 683.41 | Upgrade |
EBITDA Margin | 26.33% | 20.92% | 7.91% | 8.17% | 39.22% | 43.07% | Upgrade |
D&A For EBITDA | 120.37 | 112.42 | 101.81 | 86.22 | 64.62 | 50.33 | Upgrade |
EBIT | 533.37 | 334.38 | 19.47 | 30.9 | 717.45 | 633.08 | Upgrade |
EBIT Margin | 21.49% | 15.66% | 1.27% | 2.15% | 35.97% | 39.90% | Upgrade |
Effective Tax Rate | 12.84% | 10.06% | 13.44% | 25.70% | 13.83% | 13.37% | Upgrade |
Revenue as Reported | 2,483 | 2,136 | 1,533 | 1,434 | 1,994 | 1,587 | Upgrade |
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.